Last reviewed · How we verify
NCT03319576
Early Feeding Following Percutaneous Gastrostomy Tube Placement
NA trial testing Feeding at 4 hours in Gastrostomy in 12 participants. Completed in 16 October 2019.
16 October 2019
Quick facts
| Lead sponsor | University of Colorado, Denver |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 30 October 2017 |
| Primary completion | 16 October 2019 |
| Estimated completion | 16 October 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Feeding at 4 hours
Conditions studied
- Gastrostomy — all drugs for Gastrostomy →
Sponsor
University of Colorado, Denver
Who can join
Adults 18 to 80, any sex, with Gastrostomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study plans to learn more about the safety of early feeding following placement of a feeding tube. Doctors in other specialties feed patients 4 hours after patients receive a feeding tube. However, Interventional Radiologists typically wait to feed patients for 24 hours following feeding tube placement. The investigator would like to demonstrate that feeding after 4 hours does not increase complications and can actually reduce the burden to patients who receive a feeding tube.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03319576
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastrostomy
Currently open trials in the same condition.
- NCT06966934 — Nasopharyngeal Airway Combined With Nasal High-flow Oxygen Therapy During Painless Gastroscopy in Obesity Patients · NA · recruiting
- NCT06585306 — High-flow Nasal Oxygen Therapy in Obese Patients Undergoing Sedative Gastroscopy · NA · recruiting
- NCT06464978 — Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy · NA · recruiting
- NCT06027242 — Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy · NA · recruiting
- NCT05618392 — Pain Assessment Following Placement of a Percutaneous Radiologic Gastrostomy and Predictive Factors · recruiting
Other University of Colorado, Denver trials
Trials by the same sponsor.
- NCT07292285 — The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial. · not yet recruiting
- NCT07021937 — Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity · Phase 3 · not yet recruiting
- NCT07453732 — Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients. · NA · not yet recruiting
- NCT07038278 — 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma · EARLY_PHASE1 · not yet recruiting
- NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03319576 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Denver
- Last refreshed: 23 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03319576.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing